BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 37154975)

  • 41. Analysis of Potassium Titanyl Phosphate Laser Settings and Voice Outcomes in the Treatment of Reinke's Edema.
    Young VN; Mallur PS; Wong AW; Mandal R; Staltari GV; Gartner-Schmidt J; Rosen CA
    Ann Otol Rhinol Laryngol; 2015 Mar; 124(3):216-20. PubMed ID: 25169585
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Office-based 532-nm pulsed KTP laser treatment of glottal papillomatosis and dysplasia.
    Koufman J
    Ann Otol Rhinol Laryngol; 2007 Apr; 116(4):317. PubMed ID: 17491534
    [No Abstract]   [Full Text] [Related]  

  • 43. Oncologic efficacy of angiolytic KTP laser treatment of early glottic cancer.
    Zeitels SM; Burns JA
    Ann Otol Rhinol Laryngol; 2014 Dec; 123(12):840-6. PubMed ID: 24970297
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Surgical outcome of different surgical modalities for adult recurrent respiratory papillomatosis.
    Liu S; Shao J
    Acta Otolaryngol; 2023 Feb; 143(2):196-200. PubMed ID: 36694999
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The Safety and Efficacy of the 445-nm Blue Laser for Operative Management of Benign Nonvascular Laryngeal Lesions.
    Balouch B; Garabet R; Maxwell PJ; Sethi HK; Bress E; Ramadan O; Sataloff RT
    J Voice; 2023 Oct; ():. PubMed ID: 37805300
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison of 532 nm Potassium Titanyl Phosphate Laser and 595 nm Pulsed Dye Laser in the Treatment of Erythematous Surgical Scars: A Randomized, Controlled, Open-Label Study.
    Keaney TC; Tanzi E; Alster T
    Dermatol Surg; 2016 Jan; 42(1):70-6. PubMed ID: 26673432
    [TBL] [Abstract][Full Text] [Related]  

  • 47. KTP laser alone or combined with bleomycin for pharyngolaryngeal hemangioma: a lesion grade-based determination of prognosis.
    Shu M; He P; Wei C
    Acta Otolaryngol; 2023; 143(6):518-523. PubMed ID: 37335214
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparing KTP and CO
    Yang J; Xie Z; Seyler BC
    Laryngoscope Investig Otolaryngol; 2022 Aug; 7(4):970-981. PubMed ID: 36000042
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Laryngeal papillomatosis with airway obstruction in an infant.
    Mikkelsen PG
    Acta Anaesthesiol Scand; 2001 May; 45(5):645-8. PubMed ID: 11309020
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Feasibility and Associated Limitations of Office-Based Laryngeal Surgery Using Carbon Dioxide Lasers.
    Hu HC; Lin SY; Hung YT; Chang SY
    JAMA Otolaryngol Head Neck Surg; 2017 May; 143(5):485-491. PubMed ID: 28208177
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Outcomes of Treating Early Glottic Neoplasms With a Potassium Titanyl Phosphate Laser.
    Nouraei SAR; Dorman EB; Macann A; Vokes DE
    Ann Otol Rhinol Laryngol; 2019 Feb; 128(2):85-95. PubMed ID: 30525920
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Intralesional Cidofovir application in recurrent laryngeal papillomatosis.
    Pudszuhn A; Welzel C; Bloching M; Neumann K
    Eur Arch Otorhinolaryngol; 2007 Jan; 264(1):63-70. PubMed ID: 17058091
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Fractional 532-nm KTP diode laser and 595-nm pulsed dye laser in treatment of facial telangiectatic erythema.
    Nam CH; Kim MH; Hong SP; Park BC
    J Cosmet Dermatol; 2019 Jun; 18(3):783-787. PubMed ID: 29974643
    [TBL] [Abstract][Full Text] [Related]  

  • 54. In-Office KTP Laser for Treating Hereditary Hemorrhagic Telangiectasia-Associated Epistaxis.
    Wu V; Kell E; Faughnan ME; Lee JM
    Laryngoscope; 2021 Mar; 131(3):E689-E693. PubMed ID: 32557619
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Use of the 445-nm Blue Laser for Management of Early Glottic Carcinoma: Preliminary 1-Year Results.
    Rosow DE; Keidar E; Pasick LJ; Casellas NJ; Anis MM
    Laryngoscope; 2024 Jun; ():. PubMed ID: 38860434
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A comparative study of pulsed 532-nm potassium titanyl phosphate laser and electrocoagulation in the treatment of spider nevi.
    Erceg A; Greebe RJ; Bovenschen HJ; Seyger MM
    Dermatol Surg; 2010 May; 36(5):630-5. PubMed ID: 20384753
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Energy delivery systems for treatment of benign prostatic hyperplasia: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2006; 6(17):1-121. PubMed ID: 23074487
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Indications of Potassium Titanyl Phosphate Laser Therapy for Slow-Flow Vascular Malformations in Oral Region.
    Abukawa H; Kono M; Hamada H; Okamoto A; Satomi T; Chikazu D
    J Craniofac Surg; 2017 May; 28(3):771-774. PubMed ID: 28468163
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Office-Based 532-Nanometer Pulsed Potassium-Titanyl-Phosphate Laser Procedures in Laryngology.
    Tibbetts KM; Simpson CB
    Otolaryngol Clin North Am; 2019 Jun; 52(3):537-557. PubMed ID: 30922560
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Office-based Management of Recurrent Respiratory Papilloma.
    Motz KM; Hillel AT
    Curr Otorhinolaryngol Rep; 2016 Jun; 4(2):90-98. PubMed ID: 27242951
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.